Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle

Journal of Clinical Investigation

Volumn 113, Issue 5, 2004, Pages 756-763

  Kim, Jason K ^a   Gimeno, Ruth E ^b,f   Higashimori, Takamasa ^a   Kim, Hyo Jeong ^a   Choi, Hyejeong ^a   Punreddy, Sandhya ^b   Mozell, Robin L ^b   Tan, Guo ^b   Stricker Krongrad, Alain ^b   Hirsch, David J ^c,d   Fillmore, Jonathan J ^a   Liu, Zhen Xiang ^a   Dong, Jianying ^a   Cline, Gary ^a   Stahl, Andreas ^e   Lodish, Harvey F ^c,d   Shulman, Gerald I ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

^c WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e PALO ALTO MEDICAL FOUNDATION   (United States)

^f PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A; ADIPONECTIN; FATTY ACID; FATTY ACID TRANSPORT PROTEIN 1; INSULIN; LONG CHAIN FATTY ACID COENZYME A LIGASE; PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; FATTY ACID TRANSPORTER; GLUCOSE; SIGNAL PEPTIDE; SLC27A1 PROTEIN, MOUSE; SLC27A4 PROTEIN, MOUSE;

ADIPOSE TISSUE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FATTY ACID METABOLISM; FATTY ACID TRANSPORT; GLUCOSE HOMEOSTASIS; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLITE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; SKELETAL MUSCLE; ANIMAL; BIOLOGICAL MODEL; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; MALE; METABOLISM; MOUSE MUTANT; PATCH CLAMP; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; CARRIER PROTEINS; DIABETES MELLITUS, TYPE 2; FATTY ACID TRANSPORT PROTEINS; FATTY ACIDS; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; GLUCOSE; INSULIN; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, KNOCKOUT; MODELS, GENETIC; MUSCLE, SKELETAL; PATCH-CLAMP TECHNIQUES; PHENOTYPE; PROTEINS; SIGNAL TRANSDUCTION;

EID: 11144355563     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200418917     Document Type: Article

References (54)

1. Shaw, J.E., Zimmet, P.Z., McCarty, D, and de Courten, M. 2000. Type 2 diabetes worldwide according to the new classification and criteria. Diabetes Care. 23(Suppl. 2):B5-B10.
2. Kahn, C.R. 1994. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes. 43:1066-1084.
3. DeFronzo, R.A. 1988. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 37:667-687.
4. Cline, G.W., et al. 1999. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N. Engl. J. Med. 341:240-246.
5. Hotamisligil, G.S., Shargill, N.S., and Spiegelman, B.M. 1993. Adipose expression of rumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 259:87-91.
6. Steppan, C.M., et al. 2001. The hormone resistin links obesity to diabetes. Nature. 409:307-312.
7. Yamauchi, T., et al. 2001. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7:941-946.
8. Hotta, K., et al. 2000. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20:1595-1599.
9. Kahn, C.R., Chen, L., and Cohen, S.E. 2000. Unraveling the mechanism of action of thiazolidinediones. J. Clin. Invest. 106:1305-1307.
10. Randle, P.J., Garland, P.B., Hales, C.N., and Newsholme, E.A. 1963. The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1:785-789.
11. McGarry, J.D. 1992. What if Minkowski had been ageusic? An alternative angle on diabetes. Science. 258:766-770.
12. Reaven, G.M. 1988. Role of insulin resistance in human disease. Diabetes. 37:1595-1607.
13. Boden, G. 2001. Obesity, free fatty acids, and insulin resistance. Current Opinion in Endocrinology & Diabetes. 8:235-239.
14. Shulman, G.I. 2000. Cellular mechanisms of insulin resistance. J. Clin. Invest. 106:171-176.
15. Kraegen, E.W., Cooney, G.J., Ye, J., and Thompson, A.L. 2001. Triglycerides, fatty acids and insulin resistance - hyperinsulinemia. Exp. Clin. Endocrinol. Diabetes. 109(Suppl.):S516-S526.
16. Boden, G., Lebed, B., Schatz, M., Homko, C., and Lemieux, S. 2001. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes. 50:1612-1617.
17. Kim, J.K., et al. 2001. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc. Natl. Acad. Sci. U. S. A. 98:7522-7527.
18. 1H NMR spectroscopy study. Diabetologia. 42:113-116.
19. 13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic patients. Diabetes. 48:1600-1606.
20. Hajri, T., Han, X.X., Bonen, A., and Abumrad, N.A. 2002. Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. J. Clin. Invest. 1091:1381-1389. doi:10.1172/JCI200214596.
21. Yu, C., et al. 2002. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277:50230-50236.
22. Schaffer, J.E., and Lodish H.F. 1994. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell. 79:427-436.
23. Abumtad, N., Coburn, C., and Ibrahimi, A. 1999. Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm. Biochim. Biophys. Acta. 1441:4-13.
24. Bonen, A., Miskovic, D., and Kiens, B. 1999. Fatty acid transporters (FABPpm, FAT, FATP) in human muscle. Can. J. Appl. Physiol. 24:515-523.
25. Faergeman, N.J., DiRusso, C.C., Elberger, A., Knudsen, J., and Black, P.N. 1997. Disruption of the Saccharomyces cerevisiae homologue to the murine fatty acid transport protein impairs uptake and growth on long-chain fatty acids. J. Biol. Chem. 272:8531-8538.
26. Hall, A.M., Smith, A.J., and Bernlohr, D.A. 2003. Characterization of the acyl CoA synthetase activity of purified murine fatty acid transport protein 1. J. Biol. Chem. 278:43008-43013.
27. Stuhlsatz-Krouper, S.M., Bennett, N.E., and Schaffer, J.E. 1998. Substitution of alanine for serine 250 in the murine fatty acid transport protein inhibits long chain fatty acid transport. J. Biol. Chem. 273:28642-28650.
28. Hatch, G.M., Smith, A.J., Xu, F.Y., Hall, A.M., and Bernlohr, D.A. 2002. FATP1 channels exogenous FA into 1,2,3-triacyl-sn-glycerol and downregulates sphingomyelin and cholesterol metabolism in growing 293 cells. J. Lipid Res. 43:1380-1389.
29. Stahl, A., Gimeno, R.E., Tartaglia, LA., and Lodish, H.F. 2001. Fatty acid transport proteins: a current view of a growing family. Trends Endocrinol. Metab. 12:266-273.
30. Gimeno, R.E., et al. 2003. Targeted deletion of fatty acid transport protein-4 results in early embryonic lethality. J. Biol. Chem. 278:49512-49516.
31. Herrmann, T., et al. 2003. Mice with targeted disruption of the fatty acid transport protein 4 (FATP4, Slc27a4) gene show features of lethal restrictive dermopathy. J. Cell. Biol. 161:1105-1115.
32. Stahl, A., Evans, J.G., Pattel, S., Hirsch, D., and Lodish, H.F. 2002. Insulin causes fatty acid transport protein translocation and enhanced fatty acid uptake in adipocytes. Dev. Cell. 2:477-488.
33. Gimeno, R.E., et al. 2003. Characterization of a heart-specific fatty acid transport protein. J. Biol. Chem. 278:16039-16044.
34. Coburn, C.T., et al. 2000. Defective uptake and utilization of long-chain fatty acids in muscle and adipose tissue of CD36 knockout mice. J. Biol. Chem. 275:32523-32529.
35. Binas, B., Danneberg, H., McWhir, J., Mullins, L., and Clark, A.J. 1999. Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization. FASEB J. 13:805-812.
36. Zou, Z., et al. 2003. Vectorial acylation in Saccharomyces cerevisiae. J. Biol. Chem. 278:16414-16422.
37. Ibrahimi, A., et al. 1999. Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. J. Biol. Chem. 274:26761-26766.
38. Coburn, C.T., Hajri, T., Ibrahimi, A., and Abumrad, N.A. 2001. Role of CD36 in membrane transport and utilization of long-chain fatty acids by different tissues. J. Mol. Neurosci. 16:117-121.
39. Kim, J.K., et al. 2001. Prevention of fat-induced insulin resistance by salicylate. J. Clin. Invest. 108:437-446. doi:10.1172/JCI200111559.
40. Bligh, E.G., and Dyer, W.J. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
41. Previs, S.F., Withers, D.J., Ren, J.-M., White, M.F., and Shulman, G.I. 2000. Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo. J. Biol. Chem. 275:38990-38994.
42. Itani, S.I., Zhou, Q., Pories, W.J., MacDonald, K.G., and Dohm, G.L. 2000. Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes. 49:1353-1358.
43. Yuan, M., et al. 2001. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKK-beta. Science. 293:1673-1677.
44. Schmitz-Peiffer, C., et al. 1997. Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rats. Diabetes. 46:169-178.
45. 307 via distinct pathways. J. Clin. Invest. 107:181-189.
46. Pederson, T.M., Kramer, D.L., and Rondinone, C.M. 2001. Serine/threonine phosphorylation of IRS-1 triggers its degradation. Possible regulation by tyrosine phosphorylation. Diabetes. 50:24-31.
47. Griffin, M.E., et al. 1999. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C θ and alterations in the insulin signaling cascade. Diabetes. 48:1270-1274.
48. Chalkley, S.M., Hettiarachchi, M., Chisholm, D.J., and Kraegen, E.W. 1998. Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat. Metabolism. 47:1121-1126.
49. Hofmann, C., et al. 1994. Altered gene expression for tumor necrosis factor-α and its receptors during drug and dietary modulation of insulin resistance. Endocrinology. 134:264-270.
50. Hotamisligil, G.S., et al. 1996. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science. 271:665-668.
51. Nagaev, I., and Smith, U. 2001. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem. Biophys. Res. Comm. 285:561-564.
52. Sentinelli, F., et al. 2002. Human resistin gene, obesity, and type 2 diabetes. Mutation analysis and population study. Diabetes. 51:860-862.
53. Arita, Y., et al. 1999. Paradoxical decrease of ah adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257:79-83.
54. Hotta, K., et al. 2001. Circulating concentrations of adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes. 50:1126-1133.